Andrew and Peggy Cherng Department of Medical Engineering, Division of Engineering and Applied Science, California Institute of Technology, Pasadena, CA, USA.
Chem Soc Rev. 2024 Jul 29;53(15):7960-7982. doi: 10.1039/d4cs00001c.
The rapid advancements in nucleic acid-based electrochemical sensors for implantable and wearable applications have marked a significant leap forward in the domain of personal healthcare over the last decade. This technology promises to revolutionize personalized healthcare by facilitating the early diagnosis of diseases, monitoring of disease progression, and tailoring of individual treatment plans. This review navigates through the latest developments in this field, focusing on the strategies for nucleic acid sensing that enable real-time and continuous biomarker analysis directly in various biofluids, such as blood, interstitial fluid, sweat, and saliva. The review delves into various nucleic acid sensing strategies, emphasizing the innovative designs of biorecognition elements and signal transduction mechanisms that enable implantable and wearable applications. Special perspective is given to enhance nucleic acid-based sensor selectivity and sensitivity, which are crucial for the accurate detection of low-level biomarkers. The integration of such sensors into implantable and wearable platforms, including microneedle arrays and flexible electronic systems, actualizes their use in on-body devices for health monitoring. We also tackle the technical challenges encountered in the development of these sensors, such as ensuring long-term stability, managing the complexity of biofluid dynamics, and fulfilling the need for real-time, continuous, and reagentless detection. In conclusion, the review highlights the importance of these sensors in the future of medical engineering, offering insights into design considerations and future research directions to overcome existing limitations and fully realize the potential of nucleic acid-based electrochemical sensors for healthcare applications.
在过去十年中,基于核酸的电化学传感器在可植入和可穿戴应用方面的快速发展,标志着个人医疗保健领域取得了重大飞跃。这项技术有望通过促进疾病的早期诊断、疾病进展的监测以及个体化治疗方案的制定,彻底改变个性化医疗。本综述探讨了该领域的最新进展,重点介绍了能够直接在各种生物流体(如血液、间质液、汗液和唾液)中实时和连续分析生物标志物的核酸传感策略。本综述深入探讨了各种核酸传感策略,强调了能够实现可植入和可穿戴应用的生物识别元件和信号转导机制的创新设计。特别关注增强基于核酸的传感器的选择性和灵敏度,这对于准确检测低水平生物标志物至关重要。将这些传感器集成到可植入和可穿戴平台中,包括微针阵列和柔性电子系统,实现了它们在体内设备中用于健康监测的应用。我们还探讨了这些传感器开发中遇到的技术挑战,例如确保长期稳定性、管理生物流体动力学的复杂性以及满足实时、连续和无试剂检测的需求。总之,本综述强调了这些传感器在未来医学工程中的重要性,为设计考虑因素和未来研究方向提供了见解,以克服现有局限性,充分实现基于核酸的电化学传感器在医疗保健应用中的潜力。